Halaman 4 - Kemoterapi Dokter Terbaik - TOP-113 dokter

Univ.-Prof. Dr. Wolfgang Johannes Köstler is a board-certified specialist for Internal Medicine, Hematology/Oncology, and Intensive Care Medicine who specializes in hematology & internal oncology, intensive care medicine. He is one of the top-rated breast cancer and sarcoma oncologist specialists and has extensive experience in the field and has received degrees from the Medical University of Vienna and the Weizmann Institute of Science. He has also had special training at Memorial Sloan-Kettering Cancer Center and Royal Prince Alfred Hospital.

Dr. Christiane Thallinger is an Austrian dermatologist and venereologist. She focuses on skin cancer and oncologic dermatology. She began her medical career in 1999. She completed dermatology training at the Medical University of Vienna. She later served as a senior physician in its Department of Dermatology.

Her expertise includes diagnosis and treatment of melanoma, basal cell carcinoma, and squamous cell carcinoma. She performs dermatosurgery, cryotherapy, and photodynamic therapy. She also manages skin side effects caused by cancer treatment.

She is active in patient care and academic research. She is recognized for her patient-centered approach and for advancing dermatologic oncology in Austria.

Pediatric Hematology and Oncology / Pediatric Oncology

Dr. Viola Fox adalah Kepala Dokter di Klinik Hematologi, Onkologi, dan Kedokteran Paliatif di BKZ Solingen. Klinik ini merupakan pusat kanker interdisipliner yang telah tersertifikasi. Dr. Fox adalah pakar terkemuka dalam terapi obat untuk penyakit tumor di Jerman dan Eropa. Dia memiliki lebih dari 15 tahun pengalaman di bidang ini.

Dia adalah anggota dari German Society of Oncology and Haemato-oncology (GDHO), German Association of Physicians, dan American Association for Cancer Research. Dr. Fox juga aktif dalam penelitian biologi molekuler. Karyanya mendukung kemajuan dalam pengobatan kanker dan diagnostik molekuler.

Bidang keahliannya meliputi kemoterapi, imunoterapi, terapi target, dan terapi radiasi. Dr. Fox dikenal karena metode-metodenya yang inovatif dan komitmen kuatnya terhadap perawatan pasien. Usahanya telah menghasilkan tingkat pemulihan yang tinggi dan pengakuan dari rekan-rekannya.

Dr. Séverine Iborra adalah Kepala Dokter Departemen Ginekologi dan Obstetri di Städtisches Klinikum Solingen. Tanggung jawabnya meliputi obstetri, ruang persalinan, unit neonatal, dan ginekologi. Departemen ini juga mencakup Klinik Senologi/Breast di Pusat Payudara Bergisches Solingen yang dipimpin oleh Dr. Manuela Seifert.

Dr. Séverine Iborra berasal dari Prancis. Ia memulai studinya di Fakultas Kedokteran Universitas Lyon dan kemudian pindah ke Universitas Albert-Ludwigs di Freiburg, tempat ia memperoleh lisensi kedokteran pada tahun 2007. Ia memperoleh gelar doktor pada tahun 2008 untuk penelitian eksperimental dalam onkologi molekuler. Dari Agustus 2008 hingga November 2013, Dr. Iborra bekerja sebagai residen di Klinik Wanita Universitas di Freiburg. Setelah lulus ujian spesialis dalam bidang ginekologi dan obstetri, ia melanjutkan kariernya sebagai spesialis di klinik yang sama. Pada November 2015, ia pindah ke Rumah Sakit Universitas RWTH Aachen sebagai dokter senior.

Di Klinik untuk Ginekologi dan Obstetri, di bawah kepemimpinan Prof. Dr. E. Stickeler, Dr. Iborra memimpin departemen obstetri dari tahun 2017 hingga 2019. Sejak Desember 2017, ia bertanggung jawab atas organisasi pendidikan di departemen, dan pada Oktober 2019, ia menjadi Manajer Dokter Senior dan Dokter Senior Personalia di klinik tersebut, posisi yang dipegangnya hingga ia pindah ke Solingen.

Selain karya ilmiahnya, dengan berbagai publikasi dan presentasi di konferensi ginekologi besar, Dr. Iborra memperdalam spesialisasi medisnya. Ia memperoleh sertifikasi dalam diagnostik dan terapi onkologi dari Kelompok Kerja Onkologi Ginekologi, serta kualifikasi tambahan dalam Patologi Serviks dan Kolposkopi (AGCPC), Uroginekologi dan Bedah Rekonstruksi Pelvik (AGUP), dan Asosiasi Profesional Ginekolog (BVF).

Pada tahun 2019, Dr. Iborra berhasil menyelesaikan spesialisasi lebih lanjut dalam "Onkologi Ginekologi" dan "Obstetri Khusus dan Kedokteran Perinatal". Ia adalah anggota aktif dari masyarakat medis Jerman terkemuka di bidangnya, termasuk Masyarakat Ginekologi dan Obstetri Jerman, Kelompok Kerja Patologi Serviks dan Kolposkopi, dan Masyarakat Jerman untuk Kedokteran Prenatal dan Kelahiran.

Perawatan yang Ditawarkan di Departemen Ginekologi Kami

• Histeroskopi dan Dilatasi dan Kuretase (D&C) untuk tujuan diagnostik dan terapeutik.
• Pemindahan temuan ovarium yang abnormal atau simptomatik, seperti kista, dengan tetap memertahankan ovarium yang tersisa.
• Ooforektomi (pengangkatan ovarium) dalam kasus kelainan atau secara preventif jika diindikasikan.
• Miomektomi (pengangkatan fibroid rahim) dengan tetap memertahankan rahim.
• Pengobatan konservatif fibroid: baik dengan pengobatan atau embolisasi yang dilakukan oleh spesialis radiologi.
• Histerektomi dengan atau tanpa pengangkatan serviks.
• Diagnosis dan klarifikasi terhadap temuan yang tidak jelas di serviks, vagina, dan vulva.
• Pengobatan displasia.
• Manajemen endometriosis.
• Pengobatan kanker untuk kanker vulva, vagina, serviks, rahim, dan ovarium.
• Pengobatan untuk inkontinensia dan/atau prolaps organ panggul.

Kapan pun memungkinkan, kami menawarkan semua prosedur sebagai perawatan minimal invasif menggunakan laparoskopi atau sistem robot Da Vinci.

Assoc. Prof. Priv.-Doz. Dr. Gerald Prager adalah seorang spesialis hematologi dan onkologi internal yang berbasis di Wina dengan pengalaman sekitar 17 hingga 19 tahun. Beliau lulus dari Universitas Kedokteran Wina. Dari tahun 2006 hingga 2011, beliau menyelesaikan residensi dan fellowship di bidang hematologi dan onkologi di sana. Pada tahun 2011, beliau menjadi Profesor Tamu di Norris Comprehensive Cancer Center (USC). Pada tahun 2012, beliau menjadi Associate Professor di MedUni Wina.

Beliau memimpin Precision Medicine in Cancer Unit. Karyanya berfokus pada kanker kolorektal, onkologi presisi, angiogenesis tumor, dan penilaian biomarker prediktif. Beliau adalah pengulas tetap untuk jurnal-jurnal terkemuka, termasuk Blood dan European Journal of Clinical Investigation.

Dr. Ercan Ozden is a specialist in internal medicine and medical oncology. He earned his medical degree and completed his residency at Istanbul University, Cerrahpaşa Faculty of Medicine. He later received a subspecialty in medical oncology at Kocaeli University Faculty of Medicine from 2016 to 2020.

Dr. Ozden has worked in medical oncology at Şırnak State Hospital. He has also served as an internal medicine specialist at Bağcılar Private Safa Hospital and Küçükçekmece Batı Bahat Hospital. He has extensive clinical experience in both internal medicine and oncology.

Associate Professor Dr. Yusuf AÇIKGÖZ
Specialization: Medical Oncology

Education:

• 2004-2011: İnönü University Faculty of Medicine
• 2011-2016: Ankara Numune Training and Research Hospital, Internal Medicine
• 2017-2022: Health Sciences University, Medical Oncology

Professional Experience:

• 2016-2017: Bingöl City Hospital, Internal Medicine
• 2021-2022: Health Sciences University, Medical Oncology
• 2022-2023: Kastamonu Education and Research Hospital, Medical Oncology
• 2023-2024: Ohio State University, Medical Oncology
• 2024-Present: Lokman Hekim University, Medical Oncology, Ankara Hospital

Clinical Trials, Courses, Certifications:

Clinical Trials:

• 2017-2021: Phase III, CheckMate-649 Study (Assistant Investigator)
• 2022-Present: Phase III, Fortitude-101 Study (Assistant Investigator)

Courses:

• 2018: Medicres Basic and Advanced Biostatistics Training Program (ongoing), Istanbul-Vienna
• 2019: Immuno-Oncology Education Course, March 1-2, 2019, Vienna, Central European Cooperative Oncology Group (CECOG)
• 2018: Good Clinical Practice Certification, April 7-8, 2018, Ankara, Health Sciences University
• 2017: Basic Oncology Training Program, November 25-26, 2017, Adana, Clinical Oncology Society
• 2016: Basic Ultrasonography Course (10 hours theoretical + 10 hours practical), September 24-25, 2016, Ankara, Turkish Emergency Medicine Association

Certifications:

• Ongoing: ECFMG Certification
• 2024: CITI Responsible Conduct of Research (The Ohio State University)
• 2024: CITI IACUC-Laboratory Animal Research (The Ohio State University)
• 2024: CITI Human Subjects Protection (The Ohio State University)
• 2024: CITI Good Clinical Practice (The Ohio State University)
• 2023: Occupational English Test (OET)
• 2019: International English Language Testing System (IELTS), Total Score: 6.5, May 26, 2019, Ankara, British Council
• 2017: USMLE Step 2 CK Exam; Score: 244, February 7, 2017
• 2016: USMLE Step 1 Exam; Score: 215, August 25, 2016

Memberships:

• American Society of Clinical Oncology (ASCO) - 2022
• Turkish Society of Medical Oncology - 2020

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

 Posts and Affiliations

Clinical Director – Multidisciplinary Breast Unit Kliniken Essen-Mitte, Germany

Lead Breast Cancer Research Program, Kliniken Essen-Mitte

Executive Board Member of the AGO (Arbeitsgemeinschaft Gynäkologische Onkologie)

 Additional Roles

ESMO Faculty – Breast Cancer

Member of AWO Gyn – Commission for plastic and reconstructive surgery

Speaker of the AGIMed – Commission for Integrative Medicine of the AGO

Member of the Organ Commission Mamma of the AGO

Scientific Director of the WSG study group

Global PI, Head of clinical investigations and trials 27

IDMC´s, Steering Boards national and international

Scientific committee of international and national symposia in breast cancer and surgical oncology

 Organization Memberships

Memberships: European Society of Medical Oncology, American Society of Clinical Oncology,

European Academy of Senology, German Cancer Society, German Society of Gynecology and

Obstetrics, Working Group for Gynecological Oncology, German Society of Senology,

 Publications

Peer reviewed Publications: 322

First/Senior Author: 38

h-Index/i10-Index 66/232

Congress Abstracts/Proceedings: 443

Books/Book Chapter: 59

Invited oral Presentations/Lectures: 1032

Diseases

• Lung Cancer
• Skin Cancers
• Gastrointestinal Cancers
• Genitourinary Cancers
• Gynecological Cancers
• Colon Cancer
• Breast Cancer
• Rare Cancers

Treatment Methods

• Individual Treatments (Comprehensive Genomic Profiling)
• Targeted Therapies
• Immunotherapy
• Cancer Vaccines
• Chemotherapy
• Clinical Research/Experimental Medical Research

Experience

• 2017- 2024: Katip Çelebi University Faculty of Medicine Atatürk Education and Research Hospital Medical Oncology Clinic Associate Professor / Lecturer
• 2022 December – 2023 March: Academic visitor Moffitt Cancer Center Cutaenous Oncology Clinic Tampa, Florida USA
• 2013- 2017: Katip Çelebi University Faculty of Medicine Atatürk Training and Research Hospital – Medical Oncology Clinic Specialist Physician
• 2012-2013: Izmir Education and Research Hospital, Medical Oncology Specialist Physician
• 2012-2012: Mersin State Hospital, Medical Oncology Specialist Physician
• 2010-2012: Dokuz Eylül University Faculty of Medicine, Department of Medical Oncology, Sub-branch Research Assistant
• June-August 2008, December 2008 – February 2009: Memorial Sloan Kettering Cancer Center Observership programme
• 2007-2009: Kartal Education and Research Hospital, Medical Oncology Sub-branch Research Assistant
• 2006-2007: Siirt State Hospital, Internal Medicine, Specialist Physician
• 2005-2006: Çukurova University Faculty of Medicine, Medical Oncology Sub-branch Research Assistant
• 2004-2005: SSK Siirt Hospital, Internal Medicine Specialist Physician
• 2003-2004: SSK Mardin Hospital, Internal Medicine Specialist Physician
• 1998-2003: SSK Izmir Training and Research Hospital, 3rd Internal Medicine Clinic, Research Assistant
• 1998-1998: SSK Izmir Training and Research Hospital Infectious Diseases Research Assistant
• 1997-1998: Izmir Ataturk Training and Research Hospital, Anesthesiology and Reanimation Clinic, Research Assistant
• 1995-1997: Şırnak Cizre Central Health Center
• 1994-1995: Şırnak İdil Oyalı Village Health Center

Professional Memberships

• Turkish Society of Medical Oncology 2008 
• (2018-2021 Term Board Member)
• Izmir Oncology Group, Board Member (2014 -…)
• Geriatric Oncology Association, Board Member (2015-…)
• Mediterranean Oncology Association Board Member (2020 -…)
• Turkish Biochemistry Association, Member, 2016
• European Society of Medical Oncology, Member, 2012
• American Society of Clinical Oncology, Member, 2008

Oncohematologist

Oncologist, Radiologist

Children's Oncologist

Head of the Department of Pediatric Hematology and Oncology.

Dr. Francesc Bosch is an expert in Chronic Lymphocytic Leukemia (CLL) and lymphomas. He leads research in the molecular causes and new treatments for CLL and other lymphoproliferative disorders.

He has published over 100 articles in leading journals, including The New England Journal of Medicine and Nature Medicine. Dr. Bosch oversees more than 80 clinical studies, from phase 1 to phase 3, and plays a key role in developing new drugs.

He is the Head of Hematology at Vall d’Hebron University Hospital and IOB Institute of Oncology. He also serves as president of GELLC and is a professor of hematology. His work has improved diagnosis and treatment for blood diseases.

Dr. Ana Oaknin is a Medical Oncologist with expertise in angiogenesis, DNA repair, and immunology. She focuses on gynecological cancers. Dr. Oaknin earned her medical degree and MD in Medical Oncology from Complutense University of Madrid. She also holds a PhD from Universidad Autonoma de Barcelona.

Dr. Oaknin is Co-Chair of the GEICO Group. She is a faculty member for the Gyn-Track in the European Society of Medical Oncology. She represents Spain in the GOG and GCIG committees. Dr. Oaknin is an active member of ASCO, ESMO, and SEOM. She has published over 100 scientific articles and presentations. She also leads several clinical trials in ovarian, cervical, and endometrial cancer.

Dr. Aleix Prat is a clinical scientist with expertise in breast cancer research, gene expression, and clinical trials. He earned his MD from the University of Barcelona. He completed his oncology fellowship at Vall d’Hebron Institute of Oncology. Dr. Prat leads the Translational Genomics and Targeted Therapeutics in Solid Tumors Group at IDIBAPS. He is also President of SOLTI and serves on the Executive Committee of The Breast International Group.

Dr. Prat has published over 160 scientific papers. His work has received 13,479 citations, and he has an H-Index of 51. He is a Tenure-Track Professor at the University of Barcelona. He also directs the Breast Pathology–Senology Master’s degree. His roles highlight his strong academic and clinical contributions to oncology.